NEW YORK STOCK EXCHANGE, INC. · ANRO
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Alto Neuroscience Inc

Alto Neuroscience Inc

Pharmaceuticals
$34.28
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
ANRO
Alto Neuroscience Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
BUY BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ANRO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ANRO catalysts
About Alto Neuroscience Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2024
Employees
68
Country
US

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$34.28
Last session
Day high
$34.28
Last session
Day low
$34.28
Last session
Previous close
$34.28
52W high
$34.89
-1.75% from high
52W low
$3.51
98% of range
Market cap
$1.3B
EPS
$-2.5300
Beta
1.51
Shares out
39.2M
Avg volume
511.3K
VWAP
$34.28
Last session
Price history computed in-house
1W
+2.02%
1M
+28.01%
3M
+62.77%
1Y
+778.97%
YTD
+92.58%
SMA 50 $27.26 · above
SMA 200 $21.07 · above
52W position 98%

ANRO overview

Veridion Score
65
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
2
Ro Khanna · Purchase
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ANRO.Congress disclosuresOpen receipt and filing context for ANRO.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ANRO Form 4 filings
Public disclosures

Congress activity in ANRO

Congress trackerOpen ticker disclosure ledger →
Federal contracts

ANRO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ANRO in this window.
Lobbying spend

ANRO lobbying filings, year to date.

Registered lobbying filings matched to Alto Neuroscience Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ANRO in this window.
Loading news for ANRO
Analyst ratings
Sovereign unlock shows live analyst consensus for ANRO.
Options
Sovereign unlock shows live options positioning for ANRO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.